Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

Credit: IndiaTimes- Published on January 19, 2021
An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech, official sources said.

Video credit: Oneindia
Published on January 16, 2021 -  01:05
Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News
Bharat Biotech has said that it will pay recipients of the vaccine Covaxin compensation if beneficiaries face any adverse effects after taking it while the vaccine remains in clinical trial mode. Watch the video for more. #Covaxin #BharatBiotech #Vaccine

You are here


💡 newsR Knowledge: Other News Mentions

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery..
Credit: IndiaTimes - Published 2 days ago



Related videos from verified sources

Hong Kong begins COVID-19 vaccinations for public with Sinovac jab 04:36
Credit: Newsflare STUDIO - Published 2 days ago 


They thought they got the Covid-19 vaccine. They were part of a trial instead 03:42
Credit: Bleacher Report AOL - Published 2 days ago 


Moderna Says Trials for COVID Variant Boost Shot Have Begun 02:39
Credit: The Street - Published 3 days ago 


You might like